Sep 21 min read

Major advance in the fight against MDR-TB: four new short and effective treatments from independent clinical trials approved by the WHO

This week, the WHO recommended four new treatments for patients with MDR-TB.

Three of the regimens were from the End TB trial, and one was from the BEAT-

Tuberculosis trial. All four new recommendations include shorter-course treatments, and

the End TB regimens include some of the first endorsements of short-course treatments

for children, adolescents, and pregnant women. Learn more here.

Recent Posts

Phumeza Tisile was treated for MDR-TB in 2010 and suffered severe side effects from the drug, kanamycin. Her experiences drove her to...

The WHO has released new guidelines for prophylactic TB treatments. Among the updates to the guidelines are adjusted dosage...

The TB-CAPT consortium released a new study recently that showed that the new Xpert MTB/XDR testing can provide signigificantly faster...